Substance
LAMIVUDINE
Global reference: every product and company linked to this substance.
- cas: 134678-17-4
- ncit: C1471
- pubchem_cid: 60825
- rxnorm: 68244
- unii: 2T8Q726O95
3TC · BCH 189, (-)- · DELSTRIGO COMPONENT LAMIVUDINE · EPIVIR · GR-109714X · GR109714X · lamivudine [INN] · LAMIVUDINE [JAN] · LAMIVUDINE [USAN] · Lamivudine [WHO-DD] · LAMIVUDINE TEVA · LAMIVUDINE TEVA PHARMA B.V.
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| MERCK & COMPANY INC. COMMON STOCK (NEW) | DELSTRIGO | Q2 2026 | $101.0M* |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (16)
- ABACAVIR AND LAMIVUDINE · VIATRIS INC. COMMON STOCK
- ABACAVIR SULFATE AND LAMIVUDINE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE · VIATRIS INC. COMMON STOCK
- ABACAVIR SULFATE; LAMIVUDINE · VIATRIS INC. COMMON STOCK
- ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE · VIATRIS INC. COMMON STOCK
- CIMDUO · VIATRIS INC. COMMON STOCK
- DELSTRIGO · MERCK & COMPANY INC. COMMON STOCK (NEW)
- DOLUTEGRAVIR, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE · VIATRIS INC. COMMON STOCK
- DUTREBIS · MERCK & COMPANY INC. COMMON STOCK (NEW)
- EPIVIR-HBV · GSK PLC AMERICAN DEPOSITARY SHARES (EACH REPRESENTING TWO ORDINARY SHARES)
- EPZICOM · VIATRIS INC. COMMON STOCK
- LAMIVUDINE · TEVA PHARMACEUTICAL INDUSTRIES LIMITED AMERICAN DEPOSITARY SHARES
- LAMIVUDINE; ZIDOVUDINE · VIATRIS INC. COMMON STOCK
- LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ · VIATRIS INC. COMMON STOCK
- SYMFI · VIATRIS INC. COMMON STOCK
- SYMFI LO · VIATRIS INC. COMMON STOCK